Beskrivning
| Land | Finland |
|---|---|
| Lista | First North Finland |
| Sektor | Informationsteknik |
| Industri | Programvara |
Aiforia Technologies Plc, Press release, February 24, 2025 10:30 a.m. EET
Aiforia to publish Financial Statements Bulletin 2024 on March 7, 2025
Aiforia will publish its Financial Statements Bulletin for January–December 2024 on Friday, March 7, 2025, at around 9.00 a.m. EET. After publication, the report will be available on the company's website at https://investors.aiforia.com/.
All interested parties are welcome to a virtual webcast event at 10:00 a.m. EET on the result publication day. The event will be chaired by CEO Jukka Tapaninen and will include a review of the company's financial performance and the progress of its strategy during the year.
The event can be followed at https://aiforia.videosync.fi/q4-2024 Participants can ask questions via chat function on the video platform.
A recording of the event and the presentation materials will be published after the event on the company's website https://investors.aiforia.com/.
Analysts and investors following the company can also attend on-site at Sanomatalo, Töölönlahdenkatu 2, Helsinki. Please register for the event by Tuesday, March 4, at 4:00 p.m. EET at the latest by sending an e-mail to ir@aiforia.com.
Further inquiries
Jukka Tapaninen, CEO, Aiforia Technologies Plc
tel. +33 61 041 6686
https://investors.aiforia.com/
Certified Adviser
UB Corporate Finance Ltd
ubcf@unitedbankers.fi
About Aiforia
Aiforia is a trusted provider of deep learning artificial intelligence (AI) solutions for pathology. Aiforia delivers software solutions that elevate diagnostic capabilities in image analysis, enabling remarkable medical discoveries now and in the future. With thousands of AI models already developed on the Aiforia platform for research use and several diagnostic solutions deployed, Aiforia is already significantly impacting pathology and healthcare.
Founded in 2013, Aiforia is a publicly traded company operating internationally with thousands of platform users across the globe. The company is headquartered in Helsinki, Finland, with offices in Cambridge, Massachusetts, and Rochester, Minnesota, and local representatives across Europe and North America. The diverse team at Aiforia includes experienced pathologists, medical scientists, AI and software developers, and a dedicated commercial team. Together, they are working to transform pathology with AI, enabling better care for each patient.
Find out more at www.aiforia.com